Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Dedov II, Melnychenko GA. The polycystic ovary syndrome. M.: Med. inform. agentstvo, 2007; 361 s. (Russian)
Andreeva EH, Semycheva TV, Vesnyna AF. Molecular-genetic aspects of polycystic ovary syndrome. Probl. Reprodukcyy. 2007;6:29-35. (Russian)
Blynova YV, Chernukha GE, Karpov YA. Features of the functional state of endothelia in women with the polycystic ovary syndrome. Kardiologiya. 2008;48(1):57-61. (Russian)
Urmanova YM, Saydnazyrkhanova MS. Parasecretion of somatotropic hormone in women with the polycystic ovary syndrome by comparison to patients with nonactive adenomas of hypophysis. International Journal of Endocrinology. 2016;3(75):56-63. (Russian)
Sheremetieva EV, Karpova EA, Derkach DA. Conservative therapy (stimulation of ovulation) of polycystic ovary syndrome. Lechashhyj vrach. 2010;4;27-34. (Russian)
Azziz R. Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature. Journal of Clinical Endocrinology and Metabolism.2006;91(3):781–5. DOI:10.1210/jc.2005-2153. PMID 16418211.
Bozdag G, Mumusoglu S, Zengin D. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;Sep 22. [Epub ahead of print]
Carmina E. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva ginecologica. 2004;56(1):1-6. PMID 14973405.
Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Practice, Research Clinical Obstetrics and Gynaecology.2004;18(5):671–83. DOI:10.1016/j.bpobgyn.2004.05.001. PMID 15380140.
Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352:1223-36. PMID 15788499.
Nafiye Y, Sevtap K, Muammer D. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Fertil. Steril. 2010;93(6):1864–9. DOI:10.1016/j.fertnstert.2008.12.024. PMID 19171332.
Noroozzadeh M, Tehrani FR, Mobarakabadi SS. Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study. Int J Impot Res. 2016;Sep 22. doi: 10.1038/ijir.2016.35. [Epub ahead of print]
Fruzzetti F, Bersi C, Parrini D. Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertil. Steril. 2002;77(5): 936–44. PMID 12009347.
Fulghesu AM, Ciampelli M. Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease. Metab. Clin. Exp. 2008;47(2):158–62. PMID 9472963.
Unfer V, Carlomagno G, Dante G. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2012;28(7):509-15.
Song DK, Sung YA, Lee H. The Role of Serum MicroRNA-6767-5p as a Biomarker for the Diagnosis of Polycystic Ovary Syndrome. PLoS One. 2016;27:11(9):e0163756. doi: 10.1371/journal.pone.0163756.
Tan X, Li S, Chang Y. Effect of metformin treatment during pregnancy on women with PCOS: a systematic review and meta-analysis. Clin Invest Med. 2016;39(4):E120-31.